The impact of CK-MB elevation in patients with acute type A aortic dissection with coronary artery involvement

Naoshi Minamidate1, Noriyuki Takashima1, Tomoaki Suzuki2

  • 1Department of Cardiovascular Surgery, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga, 520-2192, Japan.

Insights

Acute type A aortic dissection with coronary artery involvement has high mortality. Elevated creatine kinase-MB (CK-MB) in these patients indicates myocardial ischemia and significantly increases surgical mortality risk.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Aortic Diseases

Background:

  • Acute type A aortic dissection (ATAAD) is a life-threatening condition necessitating emergency surgery.
  • Coronary artery involvement in ATAAD is associated with increased mortality.
  • The impact of creatine kinase muscle and brain isoenzyme (CK-MB) elevation on surgical outcomes in ATAAD with coronary artery involvement remains unclear.

Purpose of the Study:

  • To compare surgical outcomes between patients with acute type A aortic dissection and coronary artery involvement, stratified by the presence or absence of CK-MB elevation.
  • To determine if CK-MB elevation in acute coronary artery involvement (ACI) affects mortality and major complications.

Main Methods:

  • Retrospective analysis of 26 patients with ATAAD and coronary artery bypass grafting due to ACI.
  • Patients were divided into two groups: MI group (with CK-MB elevation) and NMI group (without CK-MB elevation).
  • Comparison of mortality and major postoperative complications between the MI and NMI groups.

Main Results:

  • Sixteen patients were in the MI group and ten in the NMI group.
  • The MI group exhibited significantly higher mortality (69% vs. 13%, p=0.03) compared to the NMI group.
  • No significant differences were observed in major complications such as ICU days, reintubation, reoperation, pneumonia, or sepsis.

Conclusions:

  • Acute coronary artery involvement occurs in 8.0% of ATAAD patients, with 62% showing myocardial ischemia indicated by CK-MB elevation.
  • Elevated CK-MB in ACI is a significant predictor of increased mortality in ATAAD surgery.
  • Prompt coronary perfusion is critical in suspected ACI cases to prevent CK-MB elevation and improve surgical outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
50
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
21
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
327